Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,18491,218,1.88 [1.46-2.43],1.3211566226849715e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18428,215,1.61 [1.33-1.94],8.399050838314976e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17921,210,1.77 [1.52-2.06],2.619465136976949e-13
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16149,195,1.96 [1.55-2.48],2.5065358049966664e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18254,215,1.59 [1.28-1.97],2.7378800427306725e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,15964,197,2.00 [1.42-2.83],8.022156286045764e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,15808,197,0.28 [0.18-0.44],6.37878240046236e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,18758,222,0.55 [0.41-0.72],2.4760536637460136e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,16149,195,0.45 [0.31-0.65],1.6768467915640417e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18801,219,2.28 [1.90-2.72],3.625630051674348e-19
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18636,214,1.45 [1.24-1.69],2.1203487853234227e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15926,198,1.54 [1.26-1.90],3.799308915519688e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18813,222,0.25 [0.15-0.42],1.222249699087399e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18636,214,0.62 [0.51-0.76],2.9669948466400167e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,16164,199,1.58 [1.31-1.90],1.6485462155815095e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18745,219,1.74 [1.37-2.22],6.226448119973551e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,16113,197,1.21 [1.11-1.31],1.2578239802338848e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18813,222,1.94 [1.59-2.37],7.027698600763987e-11
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,18160,214,0.51 [0.37-0.71],6.280343407342999e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18521,215,2.44 [1.68-3.56],3.36952542224536e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15723,193,2.22 [1.68-2.92],1.4452162230350272e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16149,195,0.41 [0.28-0.59],1.3822469103951254e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18512,211,1.53 [1.28-1.83],2.810029678055509e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,16087,199,1.48 [1.24-1.77],1.077587281706462e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18491,218,1.25 [1.12-1.39],7.316262279244351e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,18582,220,0.62 [0.50-0.76],6.53823029947583e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,18582,220,0.42 [0.28-0.62],1.431178753370044e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18490,217,0.39 [0.25-0.62],4.858495735683853e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18669,218,1.90 [1.39-2.62],7.227844767514418e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16168,199,2.33 [1.56-3.50],4.1400346049120345e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18758,222,1.42 [1.21-1.65],9.291880418938528e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",18544,219,1.45 [1.25-1.69],1.362049219822441e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18545,213,1.76 [1.35-2.28],2.9044636008196485e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18768,219,1.81 [1.46-2.24],7.85403097807907e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,16113,197,2.40 [1.63-3.54],9.46280142904202e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16168,199,3.08 [1.94-4.89],1.898510368538056e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18707,220,1.88 [1.37-2.59],9.353413484583344e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,18669,218,0.43 [0.29-0.62],6.976405482507943e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18624,218,1.90 [1.58-2.28],8.454854844131616e-12
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15884,191,2.51 [1.80-3.49],4.917067457139117e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18745,219,0.31 [0.18-0.55],4.1149156575527705e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,16122,199,1.83 [1.41-2.37],5.297440363840416e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,18636,214,0.57 [0.43-0.74],3.406357554954643e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,16105,197,3.52 [1.96-6.33],2.471822936585168e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,18354,218,2.10 [1.57-2.80],4.705893605568544e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18430,211,2.65 [1.83-3.85],2.96130302648832e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18745,219,0.45 [0.31-0.65],2.704660587268121e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15790,195,3.28 [2.03-5.28],1.0881016371378204e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,18615,214,1.33 [1.18-1.49],1.778048058633308e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,16168,199,0.30 [0.17-0.53],3.776553437257731e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,16125,199,4.27 [2.58-7.09],1.806144980909895e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,18160,214,1.59 [1.32-1.91],9.70275849633866e-07
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,18579,217,1.66 [1.40-1.98],1.2446511551345889e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16149,195,2.14 [1.47-3.10],6.846235750637044e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,15660,193,0.39 [0.26-0.60],1.705147511762918e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,16092,200,1.36 [1.17-1.59],5.868909521313704e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18605,218,0.40 [0.25-0.63],8.730677412811271e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18428,215,1.40 [1.21-1.62],6.9632917340768045e-06
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18782,222,2.74 [1.91-3.95],5.595617721643514e-08
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18428,215,0.41 [0.31-0.55],1.162354423632775e-09
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18545,213,1.54 [1.25-1.90],6.277331317247893e-05
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17636,202,2.54 [2.03-3.16],1.436049897553313e-16
Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18254,215,1.55 [1.28-1.87],7.140872921672466e-06
